This message was sent to ##Email##
|
| November 9, 2016 |
| |  | | |
|
|
|
| |
Medical Xpress
Every year 800,000 women die of cervical and breast cancer, but where a woman lives will largely determine her chance of survival. Two thirds of breast cancer deaths and 9 out of 10 deaths from cervical cancer occur in low- and middle income countries. While some diagnostic and treatment services like mammography and radiotherapy are likely unaffordable, several proven, high-impact, cost-effective interventions exist to tackle these common cancers and have the potential to prevent hundreds of thousands of deaths every year, yet are often not available.
READ MORE
ASCT
Volunteer cytotechnologists are being sought for a Cervical Cancer Screening campaign in Haiti. The clinic will be conducted at the Albert Sweitzer Hospital. Participants must be comfortable working in a third world country. Expected workload is 50 conventional Pap Smears per day. If you are interested, please submit a current resume to Suzy Faggard, sfaggard@aol.com. The clinic is a two week campaign in March 2017. Some travel funding is available to qualified volunteers.
For additional volunteer opportunities visit:
http://www.asct.com/content/volunteer-opportunities.
| Date |
Event |
Location |
More information |
Jan. 18, 2017
2 p.m. EST
|
Simple & Potentially Life Saving, Exfoliative Anal Cytology |
Your PC |
 Charles D. Sturgis, MD
Associate Professor of Pathology
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland Clinic Staff Cytopathologist
R.J. Tomsich Pathology & Lab Medicine Institute
More info |
Register
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
News-Medical
Standard-of-care treatment for locally advanced cervical cancer includes radiation, chemotherapy and brachytherapy (in which radiation is implanted internally). A University of Colorado Cancer Center study published in the journal Gynecologic Oncology shows that only 44 percent of patients in a large, national sample received all three components of this accepted, best treatment.
READ MORE
 |
|
The Cyto-Tek® 2500 offers excellent
preservation of cellular structure and consistently delivers a high rate of
cellular recovery. With its patented paced acceleration feature, the instrument
automatically increases and decreases the rotational velocity based on the selected
speed, which protects fragile cells and results in higher cellular yield.
|
|
Forbes
Adolescents can now protect themselves from six different types of cancer caused by human papillomavirus with just two shots of the HPV vaccine instead of three. In a move that public health officials have expected for a while, the Advisory Committee on Immunization Practices at the Centers for Disease Control and Prevention recommended that boys and girls receive two doses of the HPV vaccine at ages 11 and 12.
READ MORE
Medscape
The development of head and neck cancers may be influenced by an individual's human papillomavirus (HPV) infection status, reveals a large-scale study that found several novel genetic loci associated with oral cavity and pharyngeal cancers. The team also showed that one variant in a gene linked to immune system regulation was associated with substantial reduction in the risk of developing oropharyngeal cancer associated with HPV infection.
READ MORE
Counsel & Heal
Cervical Cancer has emerged as a large problem for many people. It is no less than any other type of cancer. It severely affects women in almost all ages. It has proven to be the fourth most common cancer that causes death. Immediate screening of cervical cancer is necessary, as the early stages do not have any particular symptoms
The examination of cervical cancer depends on the vaccine that patient has taken. This article gives a brief overview of cervical cancer, Human Papillomavirus and the screenings required after infection with HPV.
READ MORE
FierceBiotech
Though the FDA hit its studies with a clinical hold last year, which it lifted after two months, small cap Advaxis has posted some updated topline data to back up previous reports that its new med can help some patients make significant gains in overall survival rates.
The midstage GOG-0265 trial was looking at its cancer vax axalimogene filolisbac in patients with persistent or recurrent metastatic (squamous or nonsquamous cell) carcinoma of the cervix.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
